Page last updated: 2024-09-03

2-(n-myristoylamino)-1-phenyl-1-propanol and vidarabine

2-(n-myristoylamino)-1-phenyl-1-propanol has been researched along with vidarabine in 1 studies

Compound Research Comparison

Studies
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Trials
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Recent Studies (post-2010)
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Studies
(vidarabine)
Trials
(vidarabine)
Recent Studies (post-2010) (vidarabine)
23074,9769741,525

Protein Interaction Comparison

ProteinTaxonomy2-(n-myristoylamino)-1-phenyl-1-propanol (IC50)vidarabine (IC50)
Dipeptidyl peptidase 4Homo sapiens (human)0.062

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bravery, CA; Hoffbrand, AV; Lewin, J; Mehta, AB; Mengubas, K; Owens, DL; Riordan, FA; Wickremasinghe, RG1

Other Studies

1 other study(ies) available for 2-(n-myristoylamino)-1-phenyl-1-propanol and vidarabine

ArticleYear
Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism.
    Oncogene, 1999, Apr-15, Volume: 18, Issue:15

    Topics: Amidohydrolases; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Death; Ceramidases; Enzyme Inhibitors; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Myristates; Propanolamines; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Vidarabine

1999